[Active Hexose Correlated Compound] also may reduce the infectiousness of treated dogs.
[Active Hexose Correlated Compound] also may reduce the infectiousness of treated dogs.
[Supplementation of] 1 g [Active Hexose Correlated Compound]/(kg body weight · d) for 1 wk prior to and throughout infection with influenza A (H1N1, PR8). Supplementation increased survival, decreased the severity of infection, and shortened recovery time following intranasal infection with flu…
[Active Hexose Correlated Compound] also increased food intake, improved blood urea nitrogen and serum creatinine levels, and reduced bone marrow suppression. Another study showed that [Active Hexose Correlated Compound] reduced myelosuppression and reversed liver injury associated with 5-fluorouracil treatment… Another study found that [Active Hexose Correlated Compound] treatment of mice inoculated with acute myeloid leukemia cells resulted in prolonged survival compared with mice that did not receive [Active Hexose Correlated Compound]
Some researchers think it might increase the activity of "natural killer cells" in people who have cancer. Animal research suggests it might also be able to protect the liver against certain poisonous chemicals and prevent diabetes… Some early research suggests that taking [Active Hexose Correlated Compound] might reduce some of the gastrointestinal side effects from chemotherapy use, such as nausea… Limited evidence suggests that taking [Active Hexose Correlated Compound] might prolong survival and improve quality of life in people with liver cancer.
Indeed, studies reported the possible beneficial effects of [Active Hexose Correlated Compound] supplementation in controlling cancers, especially in a combination with other anticancer therapies like chemotherapy… Immunotherapy targeting these molecules has made substantial impacts in oncology by improving the survival of patients with cancers such as non-small cell lung cancer, bladder cancer, and melanoma… [Active Hexose Correlated Compound] supplementation (3 g/day) enhanced NK cell activity in a small number of patients with various cancers including the prostate.
An Unexpected Threat to HPV: a nutritional supplement derived from mushrooms shows promise in treating the incurable cancer-causing virus.
[Active Hexose Correlated Compound] helps the immune system’s ability to recognize tumors and viruses; it helps strengthen the effects of chemotherapy, it helps protect the immune system from chemotherapy’s side effects, and prevents metastasis; it protects the liver; and it guards against viral infections. [Active Hexose Correlated Compound] supports immune health by increasing natural killer (NK) cell activity and enhancing the effects of killer T-cells and cytokines (interferon, IL-12, TNF-a).
[Active Hexose Correlated Compound] as a functional food improved the cumulative five-year survival rates of Stage IA to Stage IIIA gastric cancer (n = 83) and Stage II to Stage III colon cancer (n = 52) patients compared to other institutions.
[The] study suggests that [Active Hexose Correlated Compound] intake could prolong the survival and improve the prognosis of patients with advanced liver cancer and delay the gradual decline of their physiological status.
